LENSAR Inc Cash Flow Conversion Efficiency
LENSAR Inc cash flow conversion efficiency. Based on the latest financial reports, LENSAR Inc (LNSR) has a cash flow conversion efficiency ratio of -0.009x as of June 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-127.00K) by net assets ($14.90 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of LENSAR Inc (2018–2025)
Cash flow conversion efficiency of LENSAR Inc from 2018 to 2025. This chart illustrates how LENSAR Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. View latest LENSAR Inc stock price today for real-time trading data and today's change.
LENSAR Inc Cash Flow Conversion Ratio Explained
LENSAR Inc cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
LENSAR Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of LENSAR Inc ranked by their cash flow conversion efficiency. Also see market value of LENSAR Inc for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Vortex Consolidated Bhd
KLSE:0060
|
0.039x |
|
DaChan Food (Asia) Limited
F:3DS
|
N/A |
|
Real Estate & E-Commerce Split Corp
TO:RS
|
-0.015x |
|
Amata VN PCL
BK:AMATAV
|
0.029x |
|
Makarony Polskie S.A.
WAR:MAK
|
0.058x |
|
Pasupati Acrylon Limited
NSE:PASUPTAC
|
0.013x |
|
Universal Inc
TW:1325
|
-0.009x |
|
Grupe S.A.B. de C.V
MX:CIDMEGA
|
0.023x |
Annual Cash Flow Conversion Efficiency for LENSAR Inc (2018–2025)
The table below shows the annual cash flow conversion efficiency of LENSAR Inc from 2018 to 2025. Review LNSR FCF generation index to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | $-26.02 Million | $-14.83 Million | 0.570x | +567.18% |
| 2024-12-31 | $18.65 Million | $-2.27 Million | -0.122x | +40.41% |
| 2023-12-31 | $47.18 Million | $-9.66 Million | -0.205x | +42.14% |
| 2022-12-31 | $41.98 Million | $-14.86 Million | -0.354x | -116.51% |
| 2021-12-31 | $54.88 Million | $-8.97 Million | -0.163x | +20.35% |
| 2020-12-31 | $67.21 Million | $-13.79 Million | -0.205x | -149.80% |
| 2019-12-31 | $-30.55 Million | $-12.59 Million | 0.412x | +347.34% |
| 2018-12-31 | $-20.46 Million | $-1.89 Million | 0.092x | -- |
About LENSAR Inc
LENSAR, Inc., a commercial-stage medical device company, focuses on designing, developing, and marketing laser systems for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism in the United System, Europe, Asia, South Korea, and internationally. The company offers the LENSAR Laser System, which incorporates a range of proprietary technologies des… Read more